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Phosphorylation of phospholamban and development of reticular Ca2+ transport were studied in crude 
membrane preparations of embryonic, newborn and adult chick heart. Maximal phosphorylation of 
phospholamban by added catalytic subunit of cyclic AMP-dependent protein kinase increases from 
embryonic day 4-15. It decreases with further development. In the same membrane preparations active 
Ca2+-uptake into vesicles of sarcoplasmic reticulum rises from day 4-7 and decreases then slightly until 
day 20. A several-fold increase in Ca2+ -transport activity occurs at the time of hatching. The data indicate 
separate genetic control for synthesis of phospholamban and sarcoplasmic reticulum Ca’+-ATPase. 
Cardiac muscle Ontogenesis Sarcoplasmic reticutum &+-transport 
Phospholamban 
1. INTRODUCTION 
Phospholamban, a protein of cardiac SR, is 
phosphorylated in perfused hearts in response top- 
adrenergic catecholamines [ 1,2]. In isolated 
fragments of SR cyclic AMP-dependent 
phosphorylation of the protein is associated with 
increases in the velocity of active Ca’+-transport 
and in the turnover of elementary steps of the 
Ca’+-ATPase [3]. We now report that 
phospholamban is synthesized early during cardiac 
muscle ontogenesis. The protein is present in chick 
embryonic hearts when catecholamines are first 
capable of altering cardiac contractility. A parallel 
study of phospholamban phosphorylation and SR 
Ca’+-uptake in crude membrane preparations 
revealed high tissue levels of the phosphoprotein 
and low activities of reticular Ca’+-transport at 
developmental stages preceding hatching. 
Abbreviations: SR, sarcoplasmic reticulum; CAMP-PrK, 
cyclic AMP-dependent protein kinase; C-subunit, 
catalytic subunit of cyclic AMP-dependent protein 
kinase; Ca-PrK, Ca’+/calmodulin-dependent protein 
kinase; DTT, dithiothreitol; PMSF, phenylmethyl- 
sulfonylfluoride; M,, relative molecular mass 
Protein kinase 
2. MATERIALS AND METHODS 
Hearts were removed from embryonated 
Leghorn chicken eggs, from newborn and from 
adult chickens. Crude membranes were prepared 
by disruption of whole hearts in 10 vol. 0.75 M 
KCI, 1 mM EDTA, 0.2 mM DTT, 0.1 mM PMSF, 
5 mM histidine-HCl (pH 7.4), with a Polytron PT 
lo-35 at a setting of 6. Homogenization was per- 
formed 3-times for 10 s each. This was followed by 
centrifugation at 150000 x g for 1 h. The pellets 
obtained were rehomogenized and sedimented as 
before. After an additional wash with 0.2 mM 
PTT, 0.1 mM PMSF, 100 mM histidine-HCI (pH 
7.4), membranes were suspended in 0.25 M 
sucrose, 10 mM histidine-HCl (pH 7.4). 
Fragmented SR was isolated as in [4]. 
Membrane phosphorylation with [T-~~P]ATP 
(Amersham) was carried out for 1 min as in [5] in 
the absence or presence of either 0.5 ,uM C-subunit 
and 1 mM EGTA or 0.5 FM calmodulin and 
0.1 mM CaClz. For inhibition of phosphoprotein 
phosphatases 15 mM NaF was included in the 
phosphorylation assay. In one series of ex- 
periments membranes were first treated with 
phosphoprotein phosphatase S in order to 
326 
Published by Elsevier Science Publishers B. V. 
00145793/83/$3.00  Federation of European Biochemical Societies 
Volume 155, number 2 FEBS LETTERS May 1983 
dephosphorylate any phospholamban that might 
have been initially present in phosphorylated form. 
For this purpose, 1 mg membrane protein/ml was 
incubated for 30 min at 25°C in 160 mM KCl, 
1 mM DTT, 50 mM Hepes-HCl (pH 7.4), with 
0.3 mg phosphatase S partly purified through the 
ethanol and ammonium sulfate steps as in [6]. The 
amount of phosphatase S is sufficient to remove 
>90% of [32P]phosphate from fully 
phosphorylated phospholamban. Treatment with 
phosphatase S was followed by 2 washes with 
KCl-Hepes buffer and suspension of membranes 
in 0.25 M sucrose, 10 mM histidine-HCl (pH 7.4). 
Phosphorylated membranes were solubilized in 
5% SDS, 1% fl-mercaptoethanol, 0.1 mM EDTA, 
50 mM Tris-HsPOd (pH 6.8) and heated for 1 min 
at 100°C. They were electrophorized in a 
SDS-urea-polyacrylamide system [7]. Following 
electrophoresis, gels were stained with Coomassie 
brilliant blue, destained, dried, and 
autoradiographed with ORWO HS 11 film. For 
quantitative evaluation respective areas were cut 
out from dried gels and counted by liquid spec- 
trometry. MI-markers were human albumin 
(67 000), ovalbumin (43 000), carbonic anhydrase 
(30000), soybean trypsin inhibitor (21500), 
cytochrome c (12800), aprotinin (6500) and 
glucagon (3480). 
Oxalate-dependent Ca’+-uptake was measured 
at 37°C in 40 mM imidazole-HCI buffer (pH 7.0) 
containing 100 mM KCl, 5 mM MgC12, 5 mM 
NazATP, 10 mM K-oxalate, 10 mM NaN3, 2 ,uM 
NaVOx, 0.2 mM EGTA, 75 PM 4’CaC1z (Amers- 
ham) of spec. act. 15 pCi/pmol and 40-8Opg 
membrane protein that had not been treated with 
phosphatase S. Reactions were started with ATP. 
They were stopped by millipore filtration (HAWP 
filters) followed by washing with 100 mM KCI, 
1 mM LaC13, 40 mM imidazole-HCl (pH 7.0). 
Linear transport rates were calculated from data 
points at 0.5, 1, 2 and 3 min measured in 
triplicates. The uptake conditions allow for 
Ca’+-accumulation into SR vesicles only. ATP- 
dependent Ca’+-transport into sarcolemmal and 
mitochondrial vesicles is inhibited by NaN03 [8] 
and NaN3 [9], respectively. To exclude possible ef- 
fects of variation in membrane orientation 
Ca2+-transport and protein phosphorylation were 
studied in the same membrane preparations. Both 
the active site of the Ca’+-ATPase and the 
phosphorylation sites of phospholamban are ex- 
posed to the cytoplasmic side of SR membranes 
131. 
Homogeneous preparations of C-subunit [lo] 
and calmodulin [l l] were prepared by standard 
procedures. Protein inhibitor of CAMP-PrK was a 
generous gift of Dr H. Haase from our laboratory. 
The inhibitor was purified 1200-fold from rabbit 
skeletal muscle [12]. Protein was determined as in 
[13] with ovalbumin as standard. 
3. RESULTS AND DISCUSSION 
Fig. 1A demonstrates the electrophoretic 
behavior of phosphoproteins contained in crude 
membranes collected quantitatively from chick 
heart homogenates as compared to phosphopro- 
teins in purified chick heart SR. A major 
phosphoprotein in both membrane preparations is 
phospholamban. The protein was identified by two 
criteria: 
(i) A characteristic change in electrophoretic 
mobility occurring during heating in the 
presence of SDS [15]. 
(ii) The effective phosphorylation by CAMP-PrK 
and Ca-PrK [la]. 
Heat treatment disaggregates phospholamban 
oligomers of Mr 20000-24000 into subunits of M, 
5500-9000. The M, of the dissociated 
phosphopolypeptide as estimated in the elec- 
trophoretic system in [7] is 6000 (fig.1). 
Phosphorylation of the polypeptide is catalyzed by 
added C-subunit and by a membrane-bound Ca- 
PrK. It was also found that the two phosphoryla- 
tions were additive. 
The extension of phosphoprotein analysis to 
membrane mixtures of developing hearts revealed 
that phospholamban is present in cardiac mem- 
branes of all developmental stages from embryonic 
day 4 onwards (fig.lB,C). For the early embryonic 
stages this conclusion relies mainly on experiments 
with C-subunit. The high amount of enzyme added 
assures an almost complete phosphorylation of 
available phospholamban molecules within the 
reaction time. [32P]Phosphate incorporated into 
phospholamban/mg membrane protein increases 
from embryonic day 4-15. It decreases with fur- 
ther development (table 1). When phospholamban 
phosphorylation by C-subunit is related to a unit 
of heart mass, the largest changes take place again 
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in the early embryonic period. Calculated values 
for nmol [32P]phospholamban/g wet heart wt in- 
crease from 84.6 at day 4 to 480.3 at day 15. Fur- 
ther development is associated with only moderate 
increases and a drop in phospholamban 
phosphorylation in aged myocardium. 
Phosphorylation with C-subunit was also carried 
out after prior dephosphorylation of membranes 
30.0 
201 
12.5 
6.5 
Q Phospholamban 
with phosphoprotein phosphatase 
[32P]Phosphate incorporation into the Mr 6Ok 
polypeptide changes only little following such 
treatment (table 1). The data indicate that 
phospholamban is present in isolated membranes 
largely in dephosphorylated form. Maximal 
phosphorylation with C-subunit may therefore be 
used as a method for rough estimation of the 
amount of phospholamban exposed to the 
medium. The method does not allow for deter- 
mination of phospholamban inside closed mem- 
brane vesicles. 
Upon addition of Ca*+ and calmodulin an en- 
dogenous Ca-PrK becomes activated. The activity 
of the enzyme varies with development. 
Ca*+/calmodulin-dependent phosphorylation of 
phospholamban as compared to phosphorylation 
by C-subunit is very low in membranes of early 
embryonic hearts (fig.1, table 1). Moreover, in 
membranes of 4-day-old and also of 6-day-old em- 
125 
WI- QPhospholemban 
3% 
Fig. 1. SDS-polyacrylamide gel electrophoresis and 
autoradiography of phosphorylated chick heart 
membranes: (A) phosphoproteins in a crude membrane 
preparation (a-c) and in SR (d,e) prepared from adult 
heart; (B) phosphorylation of crude membranes from 
developing hearts by C-subunit; (C) Ca*+/calmodulin- 
dependent phosphorylation of crude membranes from 
developing hearts. Embryonic ages were determined by 
comparison with the description in [ 141. Hatching occurs 
on day 21. The amount of protein applied/lane was 
100 pg for crude membranes and 30 pg for purified SR. 
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Table 1 
Phospholamban phosphorylation and oxalate-supported Ca2+ -uptake in mixed membrane preparations of embryonic, 
developing and adult chick heart 
Developmental stage Embryonic period Postnatal period 
(days): 4 7 15 20 23 31 >500 
Membrane protein 
(mg/g wet heart wt) 6.0 +_ 0.8 3.8 + 0.5 8.8 f 1.0 14.5 f 1.2 18.6 + 1.0 20.2 + 1.0 18.9 f 1.4 
[32P]Phospho1amban 
(pm01 32P/mg 
membrane protein) 
Phosphorylation in the 
presence of C-subunit 14.1 + 1.0 27.2 f 2.3 54.8 + 2.9 34.0 f 3.2 38.3 f 1.5 28.3 + 2.2 18.4 f 2.5 
Phosphorylation in the 
presence of Ca2+ and 
calmodulin 1.4 f 0.3 4.5 + 0.7 28.8 * 4.7 38.0 f 3.2 28.9 + 2.7 21.3 + 4.1 10.8 f 2.2 
Phosphorylation of 
phosphatase S-treated 
membranes with 
C-subunit n.d. n.d. 49.7 + 2.2 35.9 f 2.0 40.0 + 5.1 38.4 + 2.9 18.7 f 3.2 
Oxalate-supported Ca2+- 
uptake (nmol Ca2+ .
min-’ . mg membrane 
protein-‘) 1.7 * 0.2 9.2 + 2.0 8.2 f 2.3 6.1 k 1.6 23.0 + 1.7 24.0 + 6.2 12.6 f 2.1 
Means + SE were calculated from experimental data obtained with 3 different membrane preparations; n.d., not 
determined. For further experimental details see section 2 
bryos, phospholamban phosphorylation measured 
in the presence of Ca2+ and calmodulin is reduced 
further by about 60% with 2.8 pg/ml of partly 
purified protein inhibitor of CAMP-PrK (not 
shown). The inhibited activity should be attributed 
to endogenous CAMP-PrK. It is evident then, that 
rather low activities of Ca-PrK are present before 
day 7. Only at later developmental stages 
phosphorylation of phospholamban is effectively 
catalyzed by a membrane-bound Ca’+-dependent 
enzyme. On the contrary, CAMP-PrK is present in 
high activities in early embryonic hearts. The ac- 
tivity of this kinase decreases with development 
[17]. Retardation in the synthesis of Ca-PrK dur- 
ing ontogenesis thus offers a unique opportunity 
for studies aimed at the physiological relevance of 
cyclic AMP-dependent as opposed to 
Ca2+/calmodu1in-dependent phosphorylation of 
phospholamban. 
In parallel with phosphorylation, Ca’+-trans- 
port activities of SR fragments were evaluated in 
mixed membrane preparations (table 2). Ca’+- 
transport activities were determined from linear 
rates of ATP-dependent Ca2+-uptake measured in 
the presence of oxalate. The rate values are pro- 
portional to Ca2+-ATPase activity [ 181. Oxalate- 
supported Ca2+ -uptake is low in membranes from 
4-day old embryos. It rises from day 4-7 and then 
decreases lightly until day 20. At the time of hatc- 
hing another steep increase occurs. The large 
enhancement in Ca2+-transport activity between 
embryonic day 20 and day 2 of postnatal ife is ac- 
companied by only minor changes in cardiac 
phospholamban. 
The early presence of phospholamban in em- 
bryonic hearts is in line with the hypothesis that the 
protein is involved in fl-adrenergic regulation of 
cardiac contraction. Catecholamines are first 
capable of altering contractility in chick embryonic 
hearts at day 4 [19]. The effects are associated with 
a rise in cellular cyclic AMP [20]. Changes in ten- 
sion development elicited by catecholamines 
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before day 5 are, however, rather small: between 
30-50%. With increasing age fl-adrenergic effects 
become manifest: a 3-4-fold increase in peak- 
twitch tension and maximal rise of tension 
development are characteristic actions of 
saturating doses of isoproterenol in ventricles of 
IZday-old embryos [ 191. At the same developmen- 
tal stages there occurs a large increase in cardiac 
phospholamban (fig.1, table 1). These changes 
take place before the onset of adrenergic neuro- 
effector transmission. Adrenergic innervation is 
not operative in embryonic chick heart before day 
16 1211, 
Experiments with isolated SR suggest that 
phosphoiamban is involved in the regulation of 
reticular Ca2+-ATPase. A close functional and 
spatial relationship of both proteins has been pro- 
posed (reviewed in [3]). The present results 
demonstrate adiss~iation of phosphol~ban syn- 
thesis and development of reticular Ca2+-transport 
during ontogenesis. The observation does not rule 
out possible regulations of SR Ca2+-ATPase by 
phospholamban. It demonstrates, however, that 
synthesis of the two proteins is under separate 
genetic control. 
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